[Expert consensus on clinical application of Compound Congrong Yizhi Capsules in treatment of vascular dementia].

Abstract

Compound Congrong Yizhi Capsules is widely used in clinic for the long-term treatment and synergistic treatment of vascular cognitive impairment. After years of clinical observation, it has an obvious curative effect on the treatement of vascular cognitive impairment and has been recommended by multiple guidelines, consensuses, and series. This consensus was formulated for the treatment of vascular dementia. On the basis of summarizing the application experience of clinicians, and combined with the existing evidence-based evidence, 11 recommendations/consensus recommendations were finally reached through the nominal group method. The indications, usage and dosage, course of treatment, medication time, concomitant medication, and precautions of Congrong Yizhi Capsules in the treatment of vascular dementia were proposed, and the safety of the clinical application was described. This consensus is applicable to the use of Compound Congrong Yizhi Capsules in the treatment of patients with vascular dementia, and can be used by clinicians from the departments of encephalopathy(neurology), geriatrics, and traditional Chinese medicine in general hospitals. This consensus has been approved by China Association of Chinese Medicine, with the number of GS/CACM 298-2022.

• Authors: Xiao Liang, Xiang-Lan Jin, Dan-Tao Peng, Rong-Juan Guo, Xing Liao, Yun-Ling Zhang
• Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica (Zhongguo Zhong Yao Za Zhi) Vol. 47 Issue 23 Pg. 6514-6519 (Dec 2022) ISSN: 1001-5302 [Print] China
• PMID: 36604898 (Publication Type: English Abstract, Journal Article)

Chemical References

• Alpinia oxyphylla fruit extract
• Drugs, Chinese Herbal
• Capsules

Topics

• Humans
• Dementia, Vascular (drug therapy)
• Drugs, Chinese Herbal (therapeutic use)
• Consensus
• Capsules
• Medicine, Chinese Traditional